Literature DB >> 21143884

Visceral fat mass determination in rodent: validation of dual-energy X-ray absorptiometry and anthropometric techniques in fat and lean rats.

Maude Gerbaix1, Lore Metz, Emeline Ringot, Daniel Courteix.   

Abstract

BACKGROUND: Because abdominal obesity is predisposed to various metabolic disorders, it is of major importance to assess and track the changes with time of this specific fat mass. The main issue for clinicians or researchers is to use techniques for assessing abdominal fat deposition and its accumulation or changes over time, without sacrificing of experimental subjects. In the rat, techniques to investigate in-vivo visceral fat mass are lacking. The purpose of the study was to validate indirect Dual-energy X-ray Absorptiometry technique and abdominal circumference measurement as tools to predict visceral adipose tissue in rats.Forty-three Wistar male rats from different body weight, fat mass and ages were included in the study. Visceral fat mass was assessed by weighing the total perirenal and peri-epididymal adipose tissues after dissection. Statistical methods were used to discriminate the best region of interest allowing the in-vivo measure of Central Fat Mass by DXA. Abdominal circumference was measured at the same time as the DXA scan.
RESULTS: A region of interest including Central Fat Mass from the whole body DXA scan (extending from L2 to L5 vertebrae), correlated strongly with ex-vivo Fat Mass (r = 0.94, p < 0.001). Abdominal circumference correlated significantly with ex-vivo Fat Mass (r = 0.82, p < 0.001) and Central Fat Mass (0.90, p < 0.001) in the whole group of rats. When dividing the whole group into lean and fat rats, correlations remained significant between Central Fat Mass and ex-vivo Fat Mass but disappeared for the lean group between abdominal circumference and ex-vivo Fat Mass.
CONCLUSIONS: This study validates the Central Fat Mass determined by DXA as a non-sacrificial technique to assess visceral fat for in-vivo investigations in rats. The abdominal circumference measure appears useful in studying overweight or obese rats. These two techniques could be convenient tools in follow-up and longitudinal studies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21143884      PMCID: PMC3014952          DOI: 10.1186/1476-511X-9-140

Source DB:  PubMed          Journal:  Lipids Health Dis        ISSN: 1476-511X            Impact factor:   3.876


  22 in total

1.  Measurement of abdominal fat by magnetic resonance imaging, dual-energy X-ray absorptiometry and anthropometry in non-obese men and women.

Authors:  E G Kamel; G McNeill; T S Han; F W Smith; A Avenell; L Davidson; P Tothill
Journal:  Int J Obes Relat Metab Disord       Date:  1999-07

2.  Measurement of abdominal fat by magnetic resonance imaging of OLETF rats, an animal model of NIDDM.

Authors:  M Ishikawa; K Koga
Journal:  Magn Reson Imaging       Date:  1998       Impact factor: 2.546

Review 3.  Measurement of soft tissue composition by dual energy X-ray absorptiometry.

Authors:  S A Jebb
Journal:  Br J Nutr       Date:  1997-02       Impact factor: 3.718

4.  Estimating intraabdominal adipose tissue in women by dual-energy X-ray absorptiometry.

Authors:  M S Treuth; G R Hunter; T Kekes-Szabo
Journal:  Am J Clin Nutr       Date:  1995-09       Impact factor: 7.045

5.  Evaluation of dual-energy X-Ray absorptiometry for body-composition assessment in rats.

Authors:  E Bertin; J C Ruiz; J Mourot; P Peiniau; B Portha
Journal:  J Nutr       Date:  1998-09       Impact factor: 4.798

6.  Fenofibrate lowers abdominal and skeletal adiposity and improves insulin sensitivity in OLETF rats.

Authors:  H J Lee; S S Choi; M K Park; Y J An; S Y Seo; M C Kim; S H Hong; T H Hwang; D Y Kang; A J Garber; D K Kim
Journal:  Biochem Biophys Res Commun       Date:  2002-08-16       Impact factor: 3.575

7.  Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample.

Authors:  T S Han; E M van Leer; J C Seidell; M E Lean
Journal:  BMJ       Date:  1995-11-25

8.  Changes in fat-free mass in obese subjects after weight loss: a comparison of body composition measures.

Authors:  K van der Kooy; R Leenen; P Deurenberg; J C Seidell; K R Westerterp; J G Hautvast
Journal:  Int J Obes Relat Metab Disord       Date:  1992-09

Review 9.  Overweight: fat distribution and health risks. Epidemiological observations. A review.

Authors:  J C Seidell; J G Hautvast; P Deurenberg
Journal:  Infusionstherapie       Date:  1989-12

Review 10.  Clinical applications of body composition measurements using DXA.

Authors:  Carlina V Albanese; Evelyn Diessel; Harry K Genant
Journal:  J Clin Densitom       Date:  2003       Impact factor: 2.963

View more
  20 in total

1.  Dual-energy X-ray absorptiometry underestimates in vivo lumbar spine bone mineral density in overweight rats.

Authors:  Rim Cherif; Laurence Vico; Norbert Laroche; Mohsen Sakly; Nebil Attia; Cedric Lavet
Journal:  J Bone Miner Metab       Date:  2017-02-01       Impact factor: 2.626

2.  Abdominal fat analyzed by DEXA scan reflects visceral body fat and improves the phenotype description and the assessment of metabolic risk in mice.

Authors:  Weiyi Chen; Jenny L Wilson; Mohammad Khaksari; Michael A Cowley; Pablo J Enriori
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-07-03       Impact factor: 4.310

3.  Comparison of the Lunar Prodigy and iDXA Dual-Energy X-ray Absorptiometers for Assessing Total and Regional Body Composition.

Authors:  Shannon A Morrison; Robert M Petri; Heather L Hunter; Dheeraj Raju; Barbara Gower
Journal:  J Clin Densitom       Date:  2015-07-21       Impact factor: 2.617

4.  The effect of long-term hypogonadism on body composition and morphometry of aged male Wistar rats.

Authors:  V Borbélyová; V Šarayová; E Renczés; J Čonka; J Janko; K Šebeková; K Štefíková; D Ostatníková; P Celec
Journal:  Physiol Res       Date:  2021-12-31       Impact factor: 1.881

5.  Phaseolus vulgaris L. Leaves Increase Short-Chain Fatty Acid (SCFA) Production, Ameliorating Early Metabolic Alterations.

Authors:  Adriana Araceli Becerril-Campos; Perla Viridiana Ocampo-Anguiano; Candelario Mondragón-Jacobo; Konisgmar Escobar-García; Mariela Camacho-Barrón; Miriam Aracely Anaya-Loyola; Ana Angélica Feregrino-Perez; Teresa García-Gasca; Santiaga Marisela Ahumada-Solórzano
Journal:  Plant Foods Hum Nutr       Date:  2022-07-12       Impact factor: 4.124

6.  (-)-Epicatechin reduces muscle waste after complete spinal cord transection in a murine model: role of ubiquitin-proteasome system.

Authors:  Cristian Gonzalez-Ruiz; Paola Cordero-Anguiano; Axayacatl Morales-Guadarrama; Rodrigo Mondragón-Lozano; Stephanie Sánchez-Torres; Hermelinda Salgado-Ceballos; Francisco Villarreal; Eduardo Meaney; Guillermo Ceballos; Nayelli Nájera
Journal:  Mol Biol Rep       Date:  2020-11-05       Impact factor: 2.316

7.  Formulation and evaluation of self-emulsifying orlistat tablet to enhance drug release and in vivo performance: factorial design approach.

Authors:  Mukund Maruti Gade; Pramod Jayadevappa Hurkadale
Journal:  Drug Deliv Transl Res       Date:  2016-06       Impact factor: 4.617

8.  Impact of an obesogenic diet program on bone densitometry, micro architecture and metabolism in male rat.

Authors:  Maude Gerbaix; Lore Metz; Fabrice Mac-Way; Cédric Lavet; Christelle Guillet; Stéphane Walrand; Aurélie Masgrau; Marie-Thérèse Linossier; Laurence Vico; Daniel Courteix
Journal:  Lipids Health Dis       Date:  2012-07-10       Impact factor: 3.876

9.  A Moderate Low-Carbohydrate Low-Calorie Diet Improves Lipid Profile, Insulin Sensitivity and Adiponectin Expression in Rats.

Authors:  Jie-Hua Chen; Caiqun Ouyang; Qiang Ding; Jia Song; Wenhong Cao; Limei Mao
Journal:  Nutrients       Date:  2015-06-11       Impact factor: 5.717

10.  Classification of different degrees of adiposity in sedentary rats.

Authors:  A S Leopoldo; A P Lima-Leopoldo; A F Nascimento; R A M Luvizotto; M M Sugizaki; D H S Campos; D C T da Silva; C R Padovani; A C Cicogna
Journal:  Braz J Med Biol Res       Date:  2016-02-23       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.